Search

ZURICH, Oct. 15, 2024 /PRNewswire/ -- https://c212.net/c/link/?t=0&l=en&o=4278453-1&h=1693407585&u=https%3A%2F%2Finsphero.com%2F&a=InSphero, the global leader in 3D cell culture technology, and scientists from the https://c212.net/c/link/?t=0&l=en&o=4278453-1&h=1436878647&u=https%3A%2F%2Fwww.fda.gov%2Fabout-fda%2Foffice-chief-scientist%2Fnational-center-toxicological-research&a=U.S.+Food+and+Drug+Administration%27s+(FDA)%C2%A0National+Center+for+Toxicological+Research(NCTR) have published the largest-ever benchmarking study on liver toxicology using [...]

MINNEAPOLIS, Sept. 24, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced it will showcase its portfolio of solutions advancing neuroscience research at the upcoming annual meeting of the Society [...]

Studies show olive oil may have protective effects on the brain, adding to other well-documented health and wellness benefits LYNDHURST, N.J., April 8, 2024 /PRNewswire/ -- Filippo Berio, one of [...]

AMERICAN FORK, Utah, April 1, 2024 /PRNewswire/ -- Biolexis Therapeutics, Inc. a clinical-stage biopharmaceutical company with a novel AI-assisted drug discovery platform technology, today announced it will present five posters [...]

SAN DIEGO, Dec. 28, 2023 /PRNewswire/ -- ChemDiv, a global leader in drug discovery solutions, announces a strategic collaboration with the University of Texas Medical Branch (UTMB) to facilitate the [...]

BANGALORE, India and SARATOGA, Calif. and ADELAIDE, Australia, Dec. 7, 2023 /PRNewswire/ -- Bugworks Research Inc., a clinical-stage biopharmaceutical company, is presenting the research findings on its novel, best-in-class, dual-acting [...]

Treatments that target inflammation directly don't always work for some people with inflammatory bowel disease. However, new drug discovery approaches that focus on the health of the intestinal lining hold [...]

SAS life science analytics help contract research organization Gunvatta expedite clinical trials and FDA reporting CARY, N.C., June 21, 2022 /PRNewswire/ -- Bringing life-changing therapies to market requires pharmaceutical companies [...]

- Merck's retrosynthesis AI software 'SYNTHIA(TM) retrosynthesis software' accelerates Standigm's synthesis capability SEOUL, South Korea, June 9, 2022 /PRNewswire/ -- Standigm Inc. ('Standigm'), the leading workflow artificial intelligence (AI) drug [...]

- Merck's retrosynthesis AI software SYNTHIA(TM) accelerates Standigm's synthesis capability SEOUL, South Korea, June 1, 2022 /PRNewswire/ -- Standigm Inc. ('Standigm'), the leading workflow artificial intelligence (AI) drug discovery company, [...]

NEWTON, Mass., Feb. 3, 2022 /PRNewswire/ -- Biotechnology company https://c212.net/c/link/?t=0&l=en&o=3433706-1&h=3285444786&u=https%3A%2F%2Flactocore.com%2F&a=Lactocore+Group has identified novel milk-derived peptides that hold potential for developing safer and more effective treatments for a range of common [...]

- Combine Standigm's AI drug discovery platform and Institut Pasteur Korea's research expertise in infectious disease - Accelerate discovery of novel anti-tubercular drug candidates by conducting RIGHT Fund's awarded projects [...]

- The collaboration aims to enhance the speed and quality of large scale, high-throughput collaborative research, both internally at Lantern Pharma and with external research partners - Lantern expects the [...]

OXFORD, England and ZURICH, Sept. 13, 2021 /PRNewswire/ -- Today, IBM Research and Arctoris announced they are investigating the application of AI and automation to accelerate closed loop molecule discovery. [...]

First treatment to prevent extreme symptoms could cut hospitalizations and stop long-hauling syndrome CALGARY, AB. and BATON ROUGE, La., Aug. 11, 2021 /PRNewswire/ -- Skymount Medical, a drug discovery company, [...]

LONDON and SAN FRANCISCO, July 19, 2021 /PRNewswire/ -- Parkinson's UK, the largest charitable funder of Parkinson's research in Europe, has announced today that it is using Collaborative Drug Discovery's [...]

Inventia Life Science, a leader in automated generation of complex 3D cell models, and PhenoVista Biosciences, a top provider of custom imaging-based phenotypic assay services, have entered into a partnership [...]

This webinar will feature a discussion of advancements and critical milestones to date in SLE research and drug discovery. It will explore key considerations for improving both research into SLE, [...]

Research shows how organs-on-a-chip can test 96 tissue models at once. CAMBRIDGE, Mass., April 13, 2021 /PRNewswire-PRWeb/ -- As models of organs on-a-chip (OOC) become major tools to aid drug [...]

-SMA Foundation and PTC Therapeutics to commit to an initial investment of up to $60 million in research to discover and develop promising regenerative treatments in neuromuscular diseases- NEW YORK [...]

Comprehensive neurovascular unit model emulates features of the human brain and blood-brain barrier BOSTON, Dec. 21, 2020 /PRNewswire/ -- Emulate, Inc., a leading provider of advanced in vitro models, today [...]

In this free webinar, the featured speakers will discuss effective ways to connect biobanks, academia and industry to make human biospecimens available for preclinical and clinical research. Attendees will learn [...]

In this free webinar, the featured speakers will discuss effective ways to connect biobanks, academia and industry to make human biospecimens available for preclinical and clinical research. Attendees will learn [...]

- ADDF's Diagnostics Accelerator partners with leading pharmaceutical companies to provide access to valuable patient samples collected from earlier clinical trials to qualified researchers for biomarker development - ADDF also [...]

LEMONT, Ill. and BUFFALO, N.Y., July 6, 2020 /PRNewswire/ --The Industrial Macromolecular Crystallography Association (IMCA), an association of pharmaceutical companies that leverages the power of high-energy X-rays to accelerate structural [...]

New study confirms hanging drop microfluidics platform for miniaturized islet perifusion assays enables high-resolution assessment of islet insulin secretion from single human islets over time. SCHLIEREN, Switzerland and BASEL, Switzerland, [...]

Disclaimer: This press release and our findings are solely intended as information for the scientific community. This content is not intended to be a substitute for professional medical advice or [...]

Cellectricon announce collaboration with StressMarq Biosciences, a leading provider of reagents for neurodegenerative disease research. Access to StressMarq's portfolio of fibrillar protein preparations strongly facilitates Cellectricon's work to decipher the [...]

- $50 million global research initiative, funded by Leonard A. Lauder, Bill Gates, Jeff and MacKenzie Bezos, among other leading philanthropists, targets resources to speed up development of blood, digital [...]

Dr. Paul Barsanti joins as Vice President, Head of Drug Discovery Dr. Mike Dillon, Chief Scientific Officer, to transition to Research Fellow in Mid-2020 Jason Throne joins as Vice President, [...]

The Singapore-based company has fostered partnerships with pharmaceutical and biotech companies, Contract Research Organizations (CROs), academia and government-linked research institutes in empowering NASH drug discovery. SINGAPORE, Oct. 26, 2019 /PRNewswire/ [...]

Study findings from EpiVario co-founders, featured in Nature, suggest target for combatting alcohol use disorder and fetal alcohol syndrome PHILADELPHIA, Oct. 23, 2019 /PRNewswire-PRWeb/ -- EpiVario, Inc., an early-stage drug [...]

NEW YORK, April 2, 2019 /PRNewswire/ -- As part of its Diagnostics Accelerator research program, the Alzheimer's Drug Discovery Foundation (ADDF) announced today a new initiative that aims to fast-track [...]

The announcement comes on World Rare Disease Day, an annual global awareness initiative designed to bring attention of rare diseases to the general public and policymakers. BOSTON and Cambridge, ENGLAND, [...]

New members offer world-class expertise in human genetics, translational research and drug discovery in oncology, inflammation and immunology CAMBRIDGE, Mass., Dec. 18, 2018 /PRNewswire/ -- Kymera Therapeutics Inc., a biotechnology [...]

Over 30 abstracts to be presented at American Society of Hematology (ASH) Annual Meeting include new data from the MMRF CoMMpass Study NORWALK, Conn., Dec. 1, 2018 /PRNewswire/ -- Today, [...]

BIRMINGHAM, Ala., Jan. 25, 2017 /PRNewswire-USNewswire/ -- Birmingham's Robert R. Meyer Foundation is supporting Southern Research's Drug Discovery program with a $500,000 gift that aims to accelerate efforts to find [...]

- MaxCyte's Proprietary GT System fosters translational development of ex vivo gene-corrected cell therapy as potential 'curative' treatment for monogenic diseases through robust, scalable manufacture process GAITHERSBURG, Md., Jan. 12, [...]

Goal to advance 'drugability' of Jumonji KDMs SAN DIEGO, March 28, 2016 /PRNewswire/ -- Forge Therapeutics, Inc., a biotechnology company discovering innovative therapeutics using a breakthrough drug discovery platform targeting [...]

MENLO PARK, Calif., March 23, 2016 /PRNewswire/ -- A new collaborative project between scientists at SRI International and physician-researchers from Stanford Cancer Institute will support development of novel drugs for [...]

BIRMINGHAM, Ala., Nov. 11, 2015 /PRNewswire-USNewswire/ -- Timothy Sellati, Ph.D., has joined Southern Research's Drug Discovery division as senior research fellow and chair, Infectious Disease Department. Sellati will lead infectious [...]

Intravenous Anisina drug product identified Efficacy in a preclinical model of neuroblastoma as monotherapy and in combination using IV delivery is retained Anisina safety assessment program has commenced FORT LAUDERDALE, [...]